Can you specify cosentyx's milligrams per psoriasis injection?

What is the standard Cosentyx dose for psoriasis?

Cosentyx contains 300 mg of secukinumab per injection for adults with plaque psoriasis. The approved regimen starts with weekly loading doses for the first five weeks, then shifts to monthly maintenance injections.

How does this dose compare to other indications?

The 300 mg amount applies to psoriasis and psoriatic arthritis with skin involvement. For patients with only psoriatic arthritis or ankylosing spondylitis, the approved amount drops to 150 mg per injection, with the option to raise it to 300 mg when additional skin coverage is needed.

Can the 300 mg dose be split into two shots?

Yes. A single 300 mg dose can be administered as two separate 150 mg injections at the same time or right after each other. This option exists for convenience when the 300 mg pen or syringe is unavailable.

When does Cosentyx’s patent expire?

Cosentyx’s primary compound patent expires in 2028, while secondary patents covering formulations and methods of use extend protection through 2034 in the U.S. Biosimilar versions are unlikely to enter until after these dates.